Literature DB >> 31774334

Minority Mycobacterium tuberculosis Genotypic Populations as an Indicator of Subsequent Phenotypic Resistance.

David M Engelthaler1, Elizabeth M Streicher2, Erin J Kelley1, Christopher J Allender1, Kristin Wiggins1, Dulce Jimenez1, Darrin Lemmer1, Eric Vittinghoff3, Grant Theron2, Frederick A Sirgel2, Robin M Warren2, John Z Metcalfe4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31774334      PMCID： PMC6890401          DOI： 10.1165/rcmb.2019-0178LE

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN： 1044-1549            Impact factor:   6.914


× No keyword cloud information.
  11 in total

1.  Evaluation of the analytical performance of the Xpert MTB/RIF assay.

Authors:  Robert Blakemore; Elizabeth Story; Danica Helb; JoAnn Kop; Padmapriya Banada; Michelle R Owens; Soumitesh Chakravorty; Martin Jones; David Alland
Journal:  J Clin Microbiol       Date:  2010-05-26       Impact factor: 5.948

2.  Cryptic Microheteroresistance Explains Mycobacterium tuberculosis Phenotypic Resistance.

Authors:  John Z Metcalfe; Elizabeth Streicher; Grant Theron; Rebecca E Colman; Christopher Allender; Darrin Lemmer; Rob Warren; David M Engelthaler
Journal:  Am J Respir Crit Care Med       Date:  2017-11-01       Impact factor: 21.405

3.  Can molecular methods detect 1% isoniazid resistance in Mycobacterium tuberculosis?

Authors:  Dorte Bek Folkvardsen; Erik Svensson; Vibeke Ø Thomsen; Erik Michael Rasmussen; Didi Bang; Jim Werngren; Sven Hoffner; Doris Hillemann; Leen Rigouts
Journal:  J Clin Microbiol       Date:  2013-02-27       Impact factor: 5.948

4.  Estimating the future burden of multidrug-resistant and extensively drug-resistant tuberculosis in India, the Philippines, Russia, and South Africa: a mathematical modelling study.

Authors:  Aditya Sharma; Andrew Hill; Ekaterina Kurbatova; Martie van der Walt; Charlotte Kvasnovsky; Thelma E Tupasi; Janice C Caoili; Maria Tarcela Gler; Grigory V Volchenkov; Boris Y Kazennyy; Olga V Demikhova; Jaime Bayona; Carmen Contreras; Martin Yagui; Vaira Leimane; Sang Nae Cho; Hee Jin Kim; Kai Kliiman; Somsak Akksilp; Ruwen Jou; Julia Ershova; Tracy Dalton; Peter Cegielski
Journal:  Lancet Infect Dis       Date:  2017-05-09       Impact factor: 25.071

5.  MYCOBACTERIA: LABORATORY METHODS FOR TESTING DRUG SENSITIVITY AND RESISTANCE.

Authors:  G CANETTI; S FROMAN; J GROSSET; P HAUDUROY; M LANGEROVA; H T MAHLER; G MEISSNER; D A MITCHISON; L SULA
Journal:  Bull World Health Organ       Date:  1963       Impact factor: 9.408

6.  Mixed Mycobacterium tuberculosis-Strain Infections Are Associated With Poor Treatment Outcomes Among Patients With Newly Diagnosed Tuberculosis, Independent of Pretreatment Heteroresistance.

Authors:  Sanghyuk S Shin; Chawangwa Modongo; Yeonsoo Baik; Christopher Allender; Darrin Lemmer; Rebecca E Colman; David M Engelthaler; Robin M Warren; Nicola M Zetola
Journal:  J Infect Dis       Date:  2018-11-05       Impact factor: 5.226

7.  Detection of Low-Level Mixed-Population Drug Resistance in Mycobacterium tuberculosis Using High Fidelity Amplicon Sequencing.

Authors:  Rebecca E Colman; James M Schupp; Nathan D Hicks; David E Smith; Jordan L Buchhagen; Faramarz Valafar; Valeriu Crudu; Elena Romancenco; Ecaterina Noroc; Lynn Jackson; Donald G Catanzaro; Timothy C Rodwell; Antonino Catanzaro; Paul Keim; David M Engelthaler
Journal:  PLoS One       Date:  2015-05-13       Impact factor: 3.240

8.  The within-host population dynamics of Mycobacterium tuberculosis vary with treatment efficacy.

Authors:  Andrej Trauner; Qingyun Liu; Laura E Via; Xin Liu; Xianglin Ruan; Lili Liang; Huimin Shi; Ying Chen; Ziling Wang; Ruixia Liang; Wei Zhang; Wang Wei; Jingcai Gao; Gang Sun; Daniela Brites; Kathleen England; Guolong Zhang; Sebastien Gagneux; Clifton E Barry; Qian Gao
Journal:  Genome Biol       Date:  2017-04-19       Impact factor: 13.583

9.  Bedaquiline Microheteroresistance after Cessation of Tuberculosis Treatment.

Authors:  Margaretha de Vos; Serej D Ley; Kristin B Wiggins; Brigitta Derendinger; Anzaan Dippenaar; Melanie Grobbelaar; Anja Reuter; Tania Dolby; Scott Burns; Marco Schito; David M Engelthaler; John Metcalfe; Grant Theron; Annelies van Rie; James Posey; Rob Warren; Helen Cox
Journal:  N Engl J Med       Date:  2019-05-30       Impact factor: 91.245

10.  The New Xpert MTB/RIF Ultra: Improving Detection of Mycobacterium tuberculosis and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing.

Authors:  Soumitesh Chakravorty; Ann Marie Simmons; Mazhgan Rowneki; Heta Parmar; Yuan Cao; Jamie Ryan; Padmapriya P Banada; Srinidhi Deshpande; Shubhada Shenai; Alexander Gall; Jennifer Glass; Barry Krieswirth; Samuel G Schumacher; Pamela Nabeta; Nestani Tukvadze; Camilla Rodrigues; Alena Skrahina; Elisa Tagliani; Daniela M Cirillo; Amy Davidow; Claudia M Denkinger; David Persing; Robert Kwiatkowski; Martin Jones; David Alland
Journal:  mBio       Date:  2017-08-29       Impact factor: 7.867
View more
  4 in total

1.  Molecular Evaluation of Fluoroquinolone Resistance in Serial Mycobacterium tuberculosis Isolates from Individuals Diagnosed with Multidrug-Resistant Tuberculosis.

Authors:  Melisa Willby; Paige Chopra; Darrin Lemmer; Katherine Klein; Tracy L Dalton; David M Engelthaler; J Peter Cegielski; James E Posey
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

2.  Melting the eis: Nondetection of Kanamycin Resistance Markers by Routine Diagnostic Tests and Identification of New eis Promoter Variants.

Authors:  Serej D Ley; Samantha Pillay; Elizabeth M Streicher; Yuri F van der Heijden; Frederik Sirgel; Brigitta Derendinger; Marianna de Kock; Sébastien Gagneux; Robin M Warren; Grant Theron; Margaretha de Vos
Journal:  Antimicrob Agents Chemother       Date:  2021-06-17       Impact factor: 5.191

3.  Dynamics of within-host Mycobacterium tuberculosis diversity and heteroresistance during treatment.

Authors:  Camus Nimmo; Kayleen Brien; James Millard; Alison D Grant; Nesri Padayatchi; Alexander S Pym; Max O'Donnell; Richard Goldstein; Judith Breuer; François Balloux
Journal:  EBioMedicine       Date:  2020-04-28       Impact factor: 8.143

4.  Comparative Performance of Genomic Methods for the Detection of Pyrazinamide Resistance and Heteroresistance in Mycobacterium tuberculosis.

Authors:  Annelies Van Rie; John Z Metcalfe; Michael G Whitfield; David M Engelthaler; Christopher Allender; Megan Folkerts; Tim H Heupink; Jason Limberis; Robin M Warren
Journal:  J Clin Microbiol       Date:  2021-11-10       Impact factor: 5.948
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.